Clinical Trial Update: Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zonisamide added to E-CPT-C for veterans with PTSD and alcohol dependence has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Post-traumatic Stress Disorder

Drugs mentioned

• E-CPT-C
• Zonisamide (zonisamide)

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED | Results posted: 2020-03-16